A detailed history of Two Sigma Securities, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Two Sigma Securities, LLC holds 84,500 shares of MRNA stock, worth $3.4 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
84,500
Previous 85,900 1.63%
Holding current value
$3.4 Million
Previous $10.2 Million 44.64%
% of portfolio
0.1%
Previous 0.12%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$96.41 - $126.61 $344,665 - $452,630
-3,575 Reduced 30.04%
8,326 $859,000
Q2 2023

Aug 14, 2023

SELL
$118.5 - $160.53 $4.57 Million - $6.18 Million
-38,525 Reduced 76.4%
11,901 $1.45 Million
Q1 2023

May 15, 2023

BUY
$135.66 - $197.02 $1.33 Million - $1.93 Million
9,813 Added 24.16%
50,426 $7.74 Million
Q4 2022

Feb 14, 2023

SELL
$118.38 - $210.04 $760,946 - $1.35 Million
-6,428 Reduced 13.66%
40,613 $7.29 Million
Q3 2022

Nov 14, 2022

BUY
$118.07 - $194.18 $2.64 Million - $4.34 Million
22,343 Added 90.46%
47,041 $5.56 Million
Q2 2022

Aug 15, 2022

SELL
$117.13 - $176.59 $1.23 Million - $1.85 Million
-10,495 Reduced 29.82%
24,698 $3.53 Million
Q1 2022

May 16, 2022

BUY
$126.46 - $235.05 $4.16 Million - $7.73 Million
32,887 Added 1426.15%
35,193 $6.06 Million
Q4 2021

Feb 14, 2022

SELL
$225.82 - $368.51 $152,428 - $248,744
-675 Reduced 22.64%
2,306 $586,000
Q3 2021

Nov 15, 2021

SELL
$221.9 - $484.47 $760,451 - $1.66 Million
-3,427 Reduced 53.48%
2,981 $1.15 Million
Q2 2021

Aug 16, 2021

BUY
$129.91 - $234.98 $495,346 - $895,978
3,813 Added 146.94%
6,408 $1.51 Million
Q1 2021

May 17, 2021

SELL
$109.18 - $185.98 $44,436 - $75,693
-407 Reduced 13.56%
2,595 $340,000
Q4 2020

Feb 16, 2021

BUY
$65.74 - $169.86 $197,351 - $509,919
3,002 New
3,002 $314,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.